Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.
Saved in:
| Title: | Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. |
|---|---|
| Authors: | Aronne LJ; Division of Endocrinology, Diabetes and Metabolism, Comprehensive Weight Control Center, Weill Cornell Medicine, New York, NY, USA. Electronic address: ljaronne@med.cornell.edu., Horn DB; Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston, TX, USA., Kokkinos AD; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece., Falcon BL; Eli Lilly and Company, Indianapolis, IN, USA., Wang H; TechData Service, King of Prussia, PA, USA., Hoffmann HT; Eli Lilly and Company, Indianapolis, IN, USA., Lee CJ; Eli Lilly and Company, Indianapolis, IN, USA., Dunn JP; Eli Lilly and Company, Indianapolis, IN, USA. |
| Source: | The American journal of medicine [Am J Med] 2026 Jul; Vol. 139 (7), pp. 913-921. Date of Electronic Publication: 2026 Mar 20. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0267200 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-7162 (Electronic) Linking ISSN: 00029343 NLM ISO Abbreviation: Am J Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1555-7162 |
|---|---|
| DOI: | 10.1016/j.amjmed.2026.03.010 |
